• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, May 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Leipzig biophysicists decipher functionality of adrenaline-binding receptor

by
June 23, 2024
in Biology
Reading Time: 4 mins read
0
Binding to the receptor (green) causes the G protein (yellow) to change its shape and release the regulatory molecule GDP.
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Every organism reacts to its environment. An external stimulus causes the body to release messengers such as adrenaline, which bind to receptors. The receptors transmit the signal to other proteins. This triggers biochemical cascades that lead to a response in the organism, such as a flight-or-fight response in case of the adrenaline-binding receptor. Drugs are often modelled based on these messengers and work by interacting with receptors. Side effects can occur if the drug binds to the wrong receptor or does not transmit the signal to the correct intracellular protein. To prevent this, scientists are studying how receptors work. In the current study, Professor Peter Hildebrand and his team from the Institute of Medical Physics and Biophysics at Leipzig University show how signal transmission through the β2 adrenergic receptor takes place at the atomic level. This is a G protein-coupled receptor (GPCR). The members of this protein superfamily are embedded in the cell membrane.

The team used computer-aided molecular dynamics simulations as well as biochemical and functional mutation analyses for their investigations. This allowed them to observe how the receptor works: by binding, the receptor changes the three-dimensional structure of intracellular G protein, which then releases the regulatory molecule GDP. In the next step, this G protein can be activated by binding its actual substrate GTP and trigger biochemical cascades in the cell. The team of researchers also found that the exact function of the receptor depends on the arrangement of various flexible structural elements. They cannot be characterised using classical structural biology methods.

Professor Hildebrand is now planning to apply the computer-aided biophysical methods to other receptor systems, such as in obesity research, a focus of medical research at Leipzig University. “Comparative studies of dynamic signalling are exciting when drugs with different profiles are used,” explains the professor of biophysical computer simulations.

Professor Peter W. Hildebrand has been researching receptors at the Faculty of Medicine at Leipzig University since 2017. From 2008–2014, he studied the structure of the photoreceptor rhodopsin with Professor Klaus-Peter Hofmann and Dr Patrick Scheerer at the Charité. He is now also collaborating with Nobel laureate Professor Brian Kobilka and cryo-electron microscopist Professor Yiorgo Skiniotis, Stanford University, US, to better understand GPCR-mediated signalling. Together, they recently elucidated the mechanism of GTP binding to the G protein and its activation, and published the results in Nature. “For the first time, we now have a comprehensive picture of the structural mechanism of receptor-mediated signalling from the outside to the inside of the cell,” says Hildebrand, summarising his research. “Alongside my collaborators, I owe this success above all to the talented young scientists Dr Hossein Batebi and Dr Guillermo Pérez-Hernández from my team.” At Leipzig University, G protein-coupled receptors are also the focus of Collaborative Research Centre (CRC) 1423, Structural Dynamics of GPCR Activation and Signaling, which is led by Professor Annette Beck-Sickinger.

Binding to the receptor (green) causes the G protein (yellow) to change its shape and release the regulatory molecule GDP.

Credit: Photo: Peter W. Hildebrand

Every organism reacts to its environment. An external stimulus causes the body to release messengers such as adrenaline, which bind to receptors. The receptors transmit the signal to other proteins. This triggers biochemical cascades that lead to a response in the organism, such as a flight-or-fight response in case of the adrenaline-binding receptor. Drugs are often modelled based on these messengers and work by interacting with receptors. Side effects can occur if the drug binds to the wrong receptor or does not transmit the signal to the correct intracellular protein. To prevent this, scientists are studying how receptors work. In the current study, Professor Peter Hildebrand and his team from the Institute of Medical Physics and Biophysics at Leipzig University show how signal transmission through the β2 adrenergic receptor takes place at the atomic level. This is a G protein-coupled receptor (GPCR). The members of this protein superfamily are embedded in the cell membrane.

The team used computer-aided molecular dynamics simulations as well as biochemical and functional mutation analyses for their investigations. This allowed them to observe how the receptor works: by binding, the receptor changes the three-dimensional structure of intracellular G protein, which then releases the regulatory molecule GDP. In the next step, this G protein can be activated by binding its actual substrate GTP and trigger biochemical cascades in the cell. The team of researchers also found that the exact function of the receptor depends on the arrangement of various flexible structural elements. They cannot be characterised using classical structural biology methods.

Professor Hildebrand is now planning to apply the computer-aided biophysical methods to other receptor systems, such as in obesity research, a focus of medical research at Leipzig University. “Comparative studies of dynamic signalling are exciting when drugs with different profiles are used,” explains the professor of biophysical computer simulations.

Professor Peter W. Hildebrand has been researching receptors at the Faculty of Medicine at Leipzig University since 2017. From 2008–2014, he studied the structure of the photoreceptor rhodopsin with Professor Klaus-Peter Hofmann and Dr Patrick Scheerer at the Charité. He is now also collaborating with Nobel laureate Professor Brian Kobilka and cryo-electron microscopist Professor Yiorgo Skiniotis, Stanford University, US, to better understand GPCR-mediated signalling. Together, they recently elucidated the mechanism of GTP binding to the G protein and its activation, and published the results in Nature. “For the first time, we now have a comprehensive picture of the structural mechanism of receptor-mediated signalling from the outside to the inside of the cell,” says Hildebrand, summarising his research. “Alongside my collaborators, I owe this success above all to the talented young scientists Dr Hossein Batebi and Dr Guillermo Pérez-Hernández from my team.” At Leipzig University, G protein-coupled receptors are also the focus of Collaborative Research Centre (CRC) 1423, Structural Dynamics of GPCR Activation and Signaling, which is led by Professor Annette Beck-Sickinger.

Tom Goetze



Journal

Nature Structural & Molecular Biology

DOI

10.1038/s41594-024-01334-2

Method of Research

Experimental study

Subject of Research

Cells

Article Title

Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor

Article Publication Date

12-Jun-2024

Share12Tweet8Share2ShareShareShare2

Related Posts

How Type VI Secretion System Loads Effectors — Biology

How Type VI Secretion System Loads Effectors

May 27, 2026
Scientists Identify Disease Genes Through Reconstruction of Ancestor to All Complex Life — Biology

Scientists Identify Disease Genes Through Reconstruction of Ancestor to All Complex Life

May 27, 2026

Protein Model Predicts SARS-CoV-2 Evolution in Detail

May 27, 2026

Temperate Phages Boost Bacteria Through Flagellar Remodeling

May 27, 2026

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    318 shares
    Share 127 Tweet 80
  • New Study Reveals Plants Can Detect the Sound of Rain

    735 shares
    Share 293 Tweet 183
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    56 shares
    Share 22 Tweet 14
  • AI-Powered Atlas Uncovers Extensive Whole-Body Damage Linked to Obesity

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Temozolomide Response by Targeting miR-19b Pathway

How Type VI Secretion System Loads Effectors

Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.